Billdal, Sweden

Carin Briving

This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Astra. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carin Briving. Retrieved from https://idiyas.com/inventor/carin-briving

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carin Briving: Innovator in Active Compounds

Introduction

Carin Briving is a notable inventor based in Billdal, Sweden. She has made significant contributions to the field of active compounds, showcasing her expertise and innovative spirit. With a patent to her name, she stands out as a prominent figure in her industry.

Latest Patents

Carin Briving holds 1 patent related to active compounds. This patent reflects her dedication to advancing scientific knowledge and practical applications in her field.

Career Highlights

Briving is currently employed at Aktiebolaget Astra, a leading company in the pharmaceutical industry. Her work there has allowed her to explore new frontiers in research and development, contributing to the company's success and innovation.

Collaborations

Throughout her career, Carin has collaborated with esteemed colleagues such as Stig Carlsson and Robert Carter. These partnerships have enriched her work and fostered a collaborative environment for innovation.

Conclusion

Carin Briving exemplifies the spirit of innovation in the field of active compounds. Her contributions and collaborations highlight her importance as an inventor in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…